Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Regan Tangjiang
- Development stage
- Phase 2
- Administration
- Oral
01
Overview
Regan Tangjiang is a traditional Chinese herbal medicine formulation, also referred to as Regan Syrup, developed for the treatment of the common cold, specifically targeting cases classified as "wind-heat syndrome" in Traditional Chinese Medicine. It is administered orally and has been evaluated in multicenter, randomized, double-blind clinical trials for its efficacy and safety in this indication. The product is considered an herbal medicine rather than a conventional pharmaceutical drug. Its precise mechanism of action has not been elucidated or standardized according to Western pharmacological targets[1][2][3].
- Brand names
- Regan TangjiangRegan Syrup
- Other names
- Regan Syrup
Beyond the preview
Go deeper on Regan Tangjiang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regan Tangjiang.